The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

FreeStyle Libre 2 (adults and children 4 years and older) FreeStyle Libre 3 (adults and children 4 years and older) Similar ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Clinics and health systems using Tidepool+ will be able to initiate the connection with their patients using FreeStyle Libre ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Clinics and health systems using Tidepool+ will be able to initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely. Tidepool+ will seamlessly merge data ...